Jasper Health, backed by General Catalyst, reduces its workforce through layoffs

Jasper Health, a startup focused on cancer care platforms, recently underwent significant layoffs, impacting several departments including engineering and product design. While the exact number of employees affected remains unconfirmed, reports suggest it could be approximately half of Jasper Health’s relatively small team, which previously consisted of around 48 employees.

Despite attempts to reach out to Jasper Health’s leadership for comment, there has been no response. The company’s CEO, Adam Pellegrini, and other key executives could not be reached via email.

Just over two years ago, in February 2022, Jasper Health secured a $25 million Series A funding round led by General Catalyst, with participation from several other investors. This brought their total venture capital raised to $31 million. Notably, General Catalyst is a prominent investor in the healthcare sector and has made significant efforts to integrate startup-led technology into the US healthcare system, including the acquisition of Suma Health earlier this year.

However, Jasper Health’s recent layoffs highlight the challenges and setbacks that even well-funded startups can face in the competitive healthcare technology landscape.